Several studies have shown an association between toxicity and UGT1A genetic variations in CRC and lung cancer, but few studies have reported gastric cancer patients’ UGT1A polymorphisms and irinotecan toxicity [12,13]. Here, UGT1A1 is linked to gastric cancer.